BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36645397)

  • 1. WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist.
    Caliò A; Marletta S; Brunelli M; Martignoni G
    Pathologica; 2022 Feb; 115(1):23-31. PubMed ID: 36645397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
    Moch H
    Pathologe; 2016 Mar; 37(2):127-33. PubMed ID: 26942728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View.
    Hora M; Albiges L; Bedke J; Campi R; Capitanio U; Giles RH; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A; Trpkov K
    Eur Urol; 2023 Feb; 83(2):97-100. PubMed ID: 36435661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification.
    Rizzo M; Caliò A; Brunelli M; Pezzicoli G; Ganini C; Martignoni G; Camillo P
    Cancer Treat Rev; 2023 May; 116():102558. PubMed ID: 37060647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of renal cell carcinoma: an update.
    Lopez-Beltran A; Cheng L; Vidal A; Scarpelli M; Kirkali Z; Blanca A; Montironi R
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):61-76. PubMed ID: 23700715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of kidney tumors: introduction of the 2004 WHO classification].
    Zou WZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):517-9. PubMed ID: 17134542
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
    Udager AM; Mehra R
    Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in the molecular classification of renal neoplasms.
    Young AN; Master VA; Amin MB
    ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal cell carcinoma diagnosis and prognosis within the context of the WHO classification 2016].
    Zimpfer A; Glass Ä; Zettl H; Maruschke M; Hakenberg OW; Erbersdobler A
    Urologe A; 2019 Sep; 58(9):1057-1065. PubMed ID: 31093717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution in the Pathologic Classification of Renal Neoplasia.
    Alaghehbandan R; Campbell SC; McKenney JK
    Urol Clin North Am; 2023 May; 50(2):181-189. PubMed ID: 36948665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective.
    Albiges L; Fay AP; McKay RR; Kaymakcalan MD; Choueiri TK
    Surg Pathol Clin; 2015 Dec; 8(4):657-62. PubMed ID: 26612219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathology of renal cell carcinoma].
    Stöhr CG; Amann K; Hartmann A
    Urologe A; 2013 Jul; 52(7):942-8. PubMed ID: 23801160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges.
    Mohanty SK; Lobo A; Cheng L
    Hum Pathol; 2023 Jun; 136():123-143. PubMed ID: 36084769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine.
    Goyal R; Gersbach E; Yang XJ; Rohan SM
    Arch Pathol Lab Med; 2013 Apr; 137(4):467-80. PubMed ID: 23544936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.
    Spector Y; Fridman E; Rosenwald S; Zilber S; Huang Y; Barshack I; Zion O; Mitchell H; Sanden M; Meiri E
    Mol Oncol; 2013 Jun; 7(3):732-8. PubMed ID: 23587442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new in the WHO 2022 classification of kidney tumours?
    Alaghehbandan R; Siadat F; Trpkov K
    Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new classification of renal tumors--what is relevant for the practice?].
    Moch H
    Praxis (Bern 1994); 2005 Aug; 94(33):1261-5. PubMed ID: 16138771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis.
    Amin MB; McKenney JK; Martignoni G; Campbell SC; Pal S; Tickoo SK
    Mod Pathol; 2022 Oct; 35(10):1306-1316. PubMed ID: 35896615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.